Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) EBIT Margin (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of EBIT Margin readings, the most recent being 32.47% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 2185.0% to 32.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 38.87%, a 465.0% increase, with the full-year FY2025 number at 38.87%, up 465.0% from a year prior.
  • EBIT Margin hit 32.47% in Q4 2025 for SBC Medical Group Holdings, down from 36.63% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 51.39% in Q2 2024 to a low of 10.62% in Q4 2024.
  • Median EBIT Margin over the past 3 years was 37.55% (2023), compared with a mean of 36.73%.
  • Biggest five-year swings in EBIT Margin: plummeted -2785bps in 2024 and later soared 2185bps in 2025.
  • SBC Medical Group Holdings' EBIT Margin stood at 38.48% in 2023, then tumbled by -72bps to 10.62% in 2024, then soared by 206bps to 32.47% in 2025.
  • The last three reported values for EBIT Margin were 32.47% (Q4 2025), 36.63% (Q3 2025), and 33.57% (Q2 2025) per Business Quant data.